Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Achim Aigner

Showing results (21-30 of 174) with videos related to

Pageof 18
Sort By:
Journal of Drug Targeting|February 16, 2008
PEG grafting of polyethylenimine (PEI) exerts different effects on DNA transfection and siRNA-induced gene targeting efficacyAnastasia Malek, Frank Czubayko, Achim Aigner
Pharmacology & Therapeutics|November 27, 2024
Recent advances in development and delivery of non-viral nucleic acid therapeutics for brain tumor therapyDonat Kögel, Achim Temme, Achim Aigner
Macromolecular Bioscience|May 18, 2013
Degradable and biocompatible poly(N,N-dimethylaminoethyl methacrylate-co-caprolactone)s as DNA transfection agentsYi Zhang, Achim Aigner, Seema Agarwal
The International Journal of Biochemistry & Cell Biology|December 6, 2005
The fibroblast growth factor-binding protein FGF-BPShaker Abuharbeid, Frank Czubayko, Achim Aigner
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 31, 2019
Ricin and Ricinus communis in pharmacology and toxicology-from ancient use and "Papyrus Ebers" to modern perspectives and "poisonous plant of the year 2018"Heike Franke, Reinhold Scholl, Achim Aigner
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 30, 2013
A chorioallantoic membrane model for the determination of anti-angiogenic effects of imatinibAybike Özcetin, Achim Aigner, Udo Bakowsky
Cancer Letters|March 8, 2011
Therapeutic targeting of the mitotic spindle checkpoint through nanoparticle-mediated siRNA delivery inhibits tumor growth in vivoPhillip Kaestner, Achim Aigner, Holger Bastians
Cancer Letters|January 7, 2018
The Special AT-rich Sequence Binding Protein 1 (SATB1) and its role in solid tumorsAnja Frömberg, Kurt Engeland, Achim Aigner
International Journal of Cancer|June 30, 2005
Ribozyme-targeting reveals the rate-limiting role of pleiotrophin in glioblastomaMarius Grzelinski, Nicole Bader, Frank Czubayko, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 6, 2013
Polymer-based delivery of RNA-based therapeutics in ovarian cancerUlrike Weirauch, Daniela Gutsch, Sabrina Höbel, et al.
Pageof 18

Showing results (21-30 of 174) with videos related to

Sort By:
Pageof 18
Journal of Drug Targeting|February 16, 2008
PEG grafting of polyethylenimine (PEI) exerts different effects on DNA transfection and siRNA-induced gene targeting efficacyAnastasia Malek, Frank Czubayko, Achim Aigner
Pharmacology & Therapeutics|November 27, 2024
Recent advances in development and delivery of non-viral nucleic acid therapeutics for brain tumor therapyDonat Kögel, Achim Temme, Achim Aigner
Macromolecular Bioscience|May 18, 2013
Degradable and biocompatible poly(N,N-dimethylaminoethyl methacrylate-co-caprolactone)s as DNA transfection agentsYi Zhang, Achim Aigner, Seema Agarwal
The International Journal of Biochemistry & Cell Biology|December 6, 2005
The fibroblast growth factor-binding protein FGF-BPShaker Abuharbeid, Frank Czubayko, Achim Aigner
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 31, 2019
Ricin and Ricinus communis in pharmacology and toxicology-from ancient use and "Papyrus Ebers" to modern perspectives and "poisonous plant of the year 2018"Heike Franke, Reinhold Scholl, Achim Aigner
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 30, 2013
A chorioallantoic membrane model for the determination of anti-angiogenic effects of imatinibAybike Özcetin, Achim Aigner, Udo Bakowsky
Cancer Letters|March 8, 2011
Therapeutic targeting of the mitotic spindle checkpoint through nanoparticle-mediated siRNA delivery inhibits tumor growth in vivoPhillip Kaestner, Achim Aigner, Holger Bastians
Cancer Letters|January 7, 2018
The Special AT-rich Sequence Binding Protein 1 (SATB1) and its role in solid tumorsAnja Frömberg, Kurt Engeland, Achim Aigner
International Journal of Cancer|June 30, 2005
Ribozyme-targeting reveals the rate-limiting role of pleiotrophin in glioblastomaMarius Grzelinski, Nicole Bader, Frank Czubayko, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 6, 2013
Polymer-based delivery of RNA-based therapeutics in ovarian cancerUlrike Weirauch, Daniela Gutsch, Sabrina Höbel, et al.
Pageof 18